Cowen And Company, LLC Corcept Therapeutics Inc Call Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $353,970 - $483,138	-20,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $551,040 - $630,840	-28,000 Reduced 57.49%	20,700 $4,000
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $972,539 - $1.19 Million	48,700 New	48,700 $44,000
Q1 2021 May 04, 2021	SELL	$23.49 - $30.56 $270,135 - $351,440	-11,500 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$16.78 - $27.3 $125,850 - $204,750	-7,500 Reduced 39.47%	11,500 $43,000
Q3 2020 Nov 03, 2020	SELL	$12.46 - $19.98 $199,360 - $319,680	-16,000 Reduced 45.71%	19,000 $23,000
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $385,000 - $639,100	35,000 New	35,000 $90,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.